Carregant...
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
BACKGROUND: Three classes of inhaler medication are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta₂‐agonists (LABA); long‐acting muscarinic antagonists (LAMA); and inhaled corticosteroids (ICS). To encourage patient adherence, two classes of medication are often combin...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513478/ https://ncbi.nlm.nih.gov/pubmed/30141826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012355.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|